Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-014713

Oruka Therapeutics, Inc. · ORKA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael R Bristow
Officer — President and CEO · Director
Period of report
Feb 12, 2015
Accepted (ET)
Feb 17, 2015 · 6:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000907654

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Feb 12, 2015A48,100$0.00A340,725D
Common Stockholding———139,082IBy Investocor Trust as sole Trustee
Common Stockholding———178,215IBy NFS Custodian for Michael Bristow's IRA

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F3$0.67Feb 12, 2015A25,900A—Feb 11, 2025Common Stock25,90025,900D

Explanation of responses